key: cord-0813614-er7165fe
authors: Weaver, Liam; Das, Anup; Saffaran, Sina; Yehya, Nadir; Chikhani, Marc; Scott, Timothy E.; Laffey, John G.; Hardman, Jonathan G.; Camporota, Luigi; Bates, Declan G.
title: Optimising respiratory support for early COVID-19 pneumonia: a computational modelling study
date: 2022-03-18
journal: Br J Anaesth
DOI: 10.1016/j.bja.2022.02.037
sha: 0178d8c7a654695a556fa4eca3f14c245dd94c6f
doc_id: 813614
cord_uid: er7165fe

BACKGROUND: Optimal respiratory support in early COVID-19 pneumonia is controversial and remains unclear. Using computational modelling, we examined whether lung injury may be exacerbated in early COVID-19 by assessing the impact of conventional oxygen therapy (COT), high-flow nasal oxygen therapy (HFNOT), continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV). METHODS: Using an established multi-compartmental cardiopulmonary simulator, we first modelled COT at a fixed FiO(2) (0.6) with elevated respiratory effort for 30 minutes in 120 spontaneously breathing patients, before initiating HFNOT, CPAP or NIV. Respiratory effort was then reduced progressively over 30 minute intervals. Oxygenation, respiratory effort and lung stress/strain were quantified. Lung-protective mechanical ventilation was also simulated in the same cohort. RESULTS: HFNOT, CPAP, and NIV improved oxygenation compared with conventional therapy, but also initially increased total lung stress and strain. Improved oxygenation with CPAP reduced respiratory effort but lung stress/strain remained elevated for CPAP >5cmH(2)O. With reduced respiratory effort, HFNOT maintained better oxygenation and reduced total lung stress, with no increase in total lung strain. Compared to 10cmH(2)O positive end-expiratory pressure (PEEP), 4cmH(2)O PEEP in NIV reduced total lung stress, but high total lung strain persisted even with less respiratory effort. Lung-protective mechanical ventilation improved oxygenation while minimising lung injury. CONCLUSIONS: The failure of non-invasive ventilatory support to reduce respiratory effort may exacerbate pulmonary injury in patients with early Covid-19 pneumonia. HFNOT reduces lung strain but achieves similar oxygenation to CPAP/NIV. Invasive mechanical ventilation may be less injurious than non-invasive support in patients with high respiratory effort.

An increasing proportion of patients with acute hypoxaemic respiratory failure due to pneumonia are initially treated using non-invasive respiratory support. As well as conventional oxygen therapy (COT), high-flow nasal oxygen therapy (HFNOT), continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) are all widely used, in the hope of improving oxygenation and avoiding the complications of tracheal intubation and mechanical ventilation [1] . Over the course of the pandemic, few studies have been able to compare directly the effectiveness of different types of non-invasive respiratory support in COVID-19 [2, 3, 4] . In a recent study of 114 COVID-19 patients on non-invasive respiratory support [5] , total lung strain was the variable most strongly associated with success or failure (intubation), but in general, there is a lack of data on the potential effects of different types of respiratory support on different indicators of lung injury. Debate is also ongoing as to whether early (pre-emptive) intubation is warranted to reduce the risk of patient self-inflicted lung injury (P-SILI) arising from high respiratory effort during non-invasive respiratory support [6, 7] .

To investigate these issues, we hypothesised a conceptual model ( Figure 1 ) in which patients with Covid-19 who initially present with acute hypoxaemia and high respiratory effort benefit from different modes of respiratory support that improve oxygenation but potentially exacerbate lung stress and strain. An optimal mode of ventilatory support would improve oxygenation while reducing respiratory effort to minimise total lung stress, strain and injury. To test this hypothesis, we adapted a computational simulator of cardiopulmonary pathophysiology to quantify oxygenation, respiratory effort and mechanical forces that could lead to lung injury after HFNOT, CPAP and NIV therapy in patients with early-stage COVID-19 pneumonia.

J o u r n a l P r e -p r o o f

This computational modelling study used a multi-compartmental cardiopulmonary simulator which has been used to examine both mechanically ventilated [8] and spontaneously breathing [9] patients with COVID-19 acute respiratory failure. The simulator includes 100 alveolar compartments which have independently configurable mechanical properties, allowing for varying levels of collapse, stiffening, disruption of gas-exchange, pulmonary vasoconstriction and vasodilation, and airway obstruction. The model represents varying levels of alveolar collapse, ventilation-perfusion mismatch, physiological shunt and dead space, and alveolar gas trapping (see Supplementary Material for further detail).

We generated a cohort of virtual patients displaying the particular characteristics of early-stage COVID-19 pneumonia. Following data in [4] , lung gas volumes and compliance were set to be relatively well-preserved by allowing levels of non-aerated and poorly aerated tissue to vary within the ranges 6-13% and 18-22% of the total lung volume, respectively. Alveolar collapse was implemented by increasing parameters representing the extrinsic pressures, threshold opening pressures, and threshold closing pressures of the affected alveolar compartments. To determine the threshold opening pressure (TOP) distribution for the collapsed alveolar compartments in each patient, a normally distributed range of values was generated with a mean of 28.9 cmH2O and a standard deviation of 10.3 cmH2O, based on the data in [10] . These values were then randomly sampled for each patient to generate a distribution with a mean in the range of 25-30 cmH2O. The threshold closing pressure (TCP) J o u r n a l P r e -p r o o f distribution was calculated in a similar manner to generate a distribution for each patient with a mean in the range of 4-6 cmH2O [10] . Poorly aerated alveoli due to the effects of pneumonia were modelled by disrupting gas exchange in the affected compartments. Hyperperfusion of gasless tissues [11] was incorporated by decreasing the vascular resistance of the collapsed compartments by 80%, causing vasodilation. Disruption of hypoxic vasoconstriction (HPV) seen in COVID-19 was included, and the presence of thrombotic complications due to microthrombi was represented by increasing vascular resistance by a factor of 5 in 14-16% of the remaining compartments [11] . The virtual cohort of 120 patients was generated by taking all possible combinations of the different levels of non-aerated tissue, poorly aerated tissue, and tissue affected by microthrombi within the ranges described above. Details of the pathophysiological characteristics of the virtual patient cohort on COT are shown in Table 1 (first   column) .

Spontaneous breathing on COT (FiO2 0.6) was simulated as described previously [9] . Respiratory support was modelled by adding additional positive pressures delivering a set FiO2 to the patient's spontaneous breathing profile during both inspiration and expiration. CPAP was simulated by providing a constant positive pressure of 5, 10 or 15 cmH2O throughout the breathing cycle delivering an FiO2 of 0.6 [4, 5] . NIV was modelled by providing different inspiratory and expiratory support pressures, while also delivering an FiO2 of 0.6. The inspiratory support pressure was set at 12 cmH2O whereas the expiratory support pressure was set to 4 cmH2O or 10 cmH2O to represent low and high PEEP settings, respectively. HFNOT was modelled as supplying pure oxygen (FiO2 = 1) at a rate of 50 J o u r n a l P r e -p r o o f 7 l/min, equivalent to providing a constant pressure of 3 cmH2O throughout the expiratory cycle [12] . To represent the high flow, the conal mixing function within the simulator was switched on.

The protocol for each patient simulation was as follows:

-COT is simulated with an FiO2 of 0.6 and an elevated respiratory effort (RE1: respiratory rate RR = 30 breaths/min, peak muscular pressure Pmus= -26 cmH2O) for 30 minutes to ensure all variables are in steady-state.

-HFNOT, CPAP or NIV is initiated. 5cmH2O CPAP delivering an FiO2 of 0.6 increased SaO2, with >10cmH2O CPAP further improving oxygenation ( Figure 2 ; Table 1 ). Failure of CPAP to decrease respiratory effort resulted in increased total lung stress and strain at all levels of CPAP (Table 1) . At higher CPAP levels, the same reduction in respiratory effort produced smaller reductions in total lung strain. Provided there was a reduction in respiratory effort, CPAP increased respiratory system compliance while reducing driving pressure and mechanical power (Table 1) .

HFNOT delivered at a rate of 50 L/min (FiO2 = 1) provided 3cmH2O CPAP and improved oxygenation ( Figure 2 ; Table 2 ). If HFNOT failed to decrease respiratory effort (columns RE1, Table 2 ), total lung stress and strain increased compared with baseline values. Reduced respiratory effort (equivalent to a reduction in pleural pressure swing of 12 cmH2O) lowered total lung strain/stress to/below baseline levels but maintaining an improvement in oxygenation. When HFNOT reduced respiratory effort, respiratory system compliance was higher compared with baseline values, accompanied by reduced driving pressure and mechanical power ( Table 2) .

Non-invasive ventilation delivering FiO2 of 0.6 (pressure support=12cmH2O; PEEP=10cmH2O) improved oxygenation (Figure 2 ; Table 3 ). Failure to reduce respiratory effort resulted in higher total J o u r n a l P r e -p r o o f lung stress and strain. A reduction in respiratory effort (equivalent to a reduction in pleural pressure swing of 14 cmH2O) lowered total lung stress but total strain remained elevated at around twice baseline values (Table 3) . Lowering PEEP to 4cmH2O also improved oxygenation and reduced total lung stress, but failed to lower total lung strain even after the maximum reduction in respiratory effort.

When patient was sedated (spontaneous respiratory effort set to zero) to facilitate protective mechanical ventilation (tidal volume:7ml kg -1 ; PEEP 5cmH2O; RR 20 breaths/min; I:E ratio 1:3, FiO2 0.6), oxygen saturation and PaO2 increased. Total lung stress, driving pressure, power, pleural pressure swing, and transpulmonary pressure swing were all reduced substantially (Table 4 ). Total lung strain was higher compared with COT and HFNOT, but lower than strain levels observed following CPAP and NIV.

Reducing VT to 6ml kg -1 and increasing PEEP to 9 cmH2O produced similar levels of oxygenation but higher total lung strain.

Increasing the threshold opening pressures of collapsed alveolar compartments in each simulation by Table 7 .2).

Higher PEEP reduced compliance due to alveolar over-distension and a lack of recruitment [13] . By contrast, the benefits of improving oxygenation with HFNOT persisted, accompanied by large reductions in respiratory effort and reducing total lung stress and strain to values at or below baseline J o u r n a l P r e -p r o o f (Supplementary Table 7 .3). Lung-protective mechanical ventilation improved oxygenation while reducing all indices of lung injury except for total lung strain (Supplementary Table 7 .4).

In this study we used a computational simulator of COVID-19 pathophysiology to quantify the effects of COT, HFNOT, CPAP and NIV in 120 virtual patients. To our knowledge, this is the first study in COVID-19 to provide data with which the effects of these three different types of non-invasive respiratory support on lung mechanics can be directly compared. The conceptual model for using respiratory support in COVID-19 illustrated in Figure 1 is supported by our resultsapplication of HFNOT, CPAP and NIV improves oxygenation but also increases stress and strain on the lung if high respiratory effort is maintained. Reduced respiratory effort is required in order to minimise lung injury and ensure that the oxygenation benefit of the provided respiratory support is also "protective". Indeed, in the presence of high respiratory effort, indices of lung injury under all forms of non-invasive respiratory support considered were uniformly higher than those produced by protective mechanical ventilation.

Our results may be particularly relevant to patients with early-stage COVID-19 pneumonia, who are often poorly recruitable, i.e. their hypoxaemia is typically not the result of widespread alveolar collapse [5] . Interestingly, however, our data align well with (and provide a potential explanation for) the results of a study into NIV conducted on thirty patients with acute hypoxic respiratory failure shortly before the COVID-19 pandemic [14] , which showed that a significant reduction of respiratory effort (equivalent to a fall in pleural pressure swing, measured by oesophageal manometry, of 10 cmH2O or more after 2 hours of NIV) was strongly associated with avoidance of intubation and represented the most accurate predictor of treatment success. Reductions in pleural pressure swings of 10 cmH2O or more after initiation of respiratory support were typically required in our simulations to bring total lung stress and strain back down to acceptable levels.

In our simulations, the effectiveness of both CPAP and NIV was highly sensitive to the values of threshold opening pressures (TOPs) in the collapsed lung regions. Increasing the average value for the threshold opening pressures by 50% severely curtailed the effectiveness of both therapies in improving oxygenationeven when this was achieved (using a CPAP of 15 cmH2O) the resulting levels of lung stress and strain (even after a reduction in respiratory effort) are likely to be compatible with the development of P-SILI [9] . Previous data suggest that a wide range of alveolar opening pressures exist in ARDSone study of 5 patients (with an average of 6% of the lung parenchyma available for recruitment) found the maximal frequency of estimated TOPs to be approximately 20 cmH2O in three patients, whereas in two other patients this maximal frequency occurred between 35-40 cmH2O [10] .

This wide distribution of estimated TOPs may reflect the particular nature of the underlying atelectasis, since pressures needed to reverse collapse of the small airways are generally lower than those required to reopen reabsorption atelectasis [10] . It is thus tempting to speculate that, since early-stage COVID-19 patients typically have low levels of gasless tissue, but highly variable recruitability, differences in TOP due to different types of COVID-19 induced collapse could be important in determining recruitability and hence response to CPAP and NIV.

A recent large clinical randomised controlled trial found that CPAP significantly reduced the risk of tracheal intubation compared with COT, among patients with acute hypoxemic respiratory failure due to COVID-19 [2] . Our data comparing the levels of stress and strain applied to the lung by HFNOT, CPAP, and NIV, suggests that HFNOT may be a more protective form of respiratory support for many patients with COVID-19, and particularly for patients with poorer recruitability (see Tables S1-3) .

Further clinical randomised controlled trials are recommended in order to confirm these results.

Our study has some limitations. The results are based on computational modelling of mechanisms that have been proposed to underlie COVID-19 pathophysiology, rather than on models matched to detailed individual data from patients with COVID-19. Accordingly, some model parameters were manually adjusted to give outputs that match reported data on COVID-19 patients, rather than being fit to data that explicitly defines the parameters. The model also neglects some physiological realities (namely spatial interdependence of alveoli, non-uniformity of diaphragmatic contraction, and gravitational effects) which would act to produce higher values of certain lung injury indices in particular lung regions. These limitations must be balanced against the unique strength of our computational modelling approach -that it allows precise quantitative comparison of different non-invasive (and protective invasive) ventilatory strategies on an identical virtual patient population.

In summary, our results suggest that, although non-invasive respiratory support uniformly improves oxygenation, reductions in respiratory effort are also required to confer a net positive effect on the total stress and strain applied to the lung. In the absence of such reductions, or when pressures applied are high, damage to the lung via self-inflicted lung injury is possible. In our virtual patient cohort, HFNOT produced similar oxygenation improvements while applying lower stresses/strains to the lung than CPAP or NIV, particularly in patients with poorer recruitability. In the presence of high respiratory effort, indices of lung injury under non-invasive respiratory support were generally higher than those produced by invasive ventilation using protective settings and control of driving pressure. Solid lines indicate a "success" casereduction in respiratory effort enabled by the support is sufficient to reduce stress and strain on the lung to acceptable levels. Dotted lines indicate a "failure" case, where reduction of respiratory effort fails to reduce stress and strain on the lung to acceptable levels, P-SILI accumulates, and oxygenation continues to deteriorate. Mean values across the cohort of 120 virtual patients. x denotes total lung stress, + denotes total lung strain.

J o u r n a l P r e -p r o o f CPAP values are compared with the baseline case of a patient receiving COT and breathing with high respiratory effort (RE1). Respiratory effort decreases progressively from RE1 to RE4. Red squares indicate increases in indices of lung injury > 5%, green squares indicate reductions in indices of lung injury > 5%, orange squares indicate a change of < 5%.

J o u r n a l P r e -p r o o f HFNOT data are compared with the baseline case of a patient receiving COT and breathing with high respiratory effort (RE1). Respiratory effort decreases progressively from RE1 to RE4. Red squares indicate increases in indices of lung injury > 5%, green squares indicate reductions in indices of lung injury > 5%, orange squares indicate a change of < 5%.

The table shows the comparison of the effect of applying NIV with different levels of PEEP versus the baseline case of a patient receiving COT and breathing with high respiratory effort (RE1). Respiratory effort decreases progressively from RE1 to RE4. Red squares indicate increases in indices of lung injury > 5%, green squares indicate reductions in indices of lung injury > 5%, orange squares indicate a change of < 5%.

J o u r n a l P r e -p r o o f

COVID-19 pneumonia: pathophysiology and management

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial

Antonelli M; and the COVID-ICU Gemelli study group. Phenotypes of COVID-19 Patients with Positive Clinical Response to Helmet Noninvasive Ventilation

Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure

Role of total lung stress on the progression of early COVID-19 pneumonia

Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies

Timing of Intubation in Covid-19 ARDS: What "time" really matters

In silico modeling of coronavirus disease 2019 acute respiratory distress syndrome: pathophysiologic insights and potential management implications

High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study

Recruitment and derecruitment during acute respiratory failure: a clinical study

COVID-19-related organ dysfunction and management strategies on the intensive care unit: a narrative review

Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle

Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease

Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study